Becton Dickinson Cash on Hand 2010-2022 | BDX

Becton Dickinson cash on hand from 2010 to 2022. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Becton Dickinson cash on hand for the quarter ending December 31, 2022 was $0.745B, a 63.75% decline year-over-year.
  • Becton Dickinson cash on hand for 2022 was $1.167B, a 51.46% decline from 2021.
  • Becton Dickinson cash on hand for 2021 was $2.404B, a 18.15% decline from 2020.
  • Becton Dickinson cash on hand for 2020 was $2.937B, a 373.71% increase from 2019.
Becton Dickinson Annual Cash on Hand
(Millions of US $)
2022 $1,167
2021 $2,404
2020 $2,937
2019 $620
2018 $1,253
2017 $14,200
2016 $1,907
2015 $1,519
2014 $2,750
2013 $2,608
2012 $2,181
2011 $1,563
2010 $1,744
2009 $1,946
Becton Dickinson Quarterly Cash on Hand
(Millions of US $)
2022-12-31 $745
2022-09-30 $1,167
2022-06-30 $2,774
2022-03-31 $3,335
2021-12-31 $2,055
2021-09-30 $2,404
2021-06-30 $3,305
2021-03-31 $3,922
2020-12-31 $3,464
2020-09-30 $2,937
2020-06-30 $2,986
2020-03-31 $2,445
2019-12-31 $617
2019-09-30 $620
2019-06-30 $606
2019-03-31 $777
2018-12-31 $1,046
2018-09-30 $1,253
2018-06-30 $1,524
2018-03-31 $1,434
2017-12-31 $1,321
2017-09-30 $14,200
2017-06-30 $13,904
2017-03-31 $911
2016-12-31 $1,283
2016-09-30 $1,907
2016-06-30 $2,046
2016-03-31 $2,022
2015-12-31 $1,629
2015-09-30 $1,519
2015-06-30 $1,718
2015-03-31 $2,129
2014-12-31 $8,784
2014-09-30 $2,750
2014-06-30 $2,639
2014-03-31 $2,626
2013-12-31 $2,513
2013-09-30 $2,608
2013-06-30 $2,299
2013-03-31 $2,421
2012-12-31 $2,512
2012-09-30 $2,181
2012-06-30 $2,188
2012-03-31 $2,112
2011-12-31 $2,694
2011-09-30 $1,563
2011-06-30 $1,921
2011-03-31 $1,858
2010-12-31 $2,247
2010-09-30 $1,744
2010-06-30 $1,445
2010-03-31 $1,258
2009-12-31 $1,458
2009-09-30 $1,946
2009-06-30 $1,752
2009-03-31 $730
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.794B $18.870B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $49.651B 14.73
AmerisourceBergen (ABC) United States $32.236B 14.06
Laboratory Of America Holdings (LH) United States $22.092B 11.07
Cardinal Health (CAH) United States $20.268B 15.67
West Pharmaceutical Services (WST) United States $20.202B 30.87
Cooper (COO) United States $17.521B 28.54
CONMED (CNMD) United States $3.128B 38.72